PX1 Research supplies high-purity Nicotinamide Adenine Dinucleotide (NAD+) to academic, clinical, and private research institutions across Texas. Synthesized in GMP-compliant facilities and verified by independent ISO 17025 accredited laboratories, our research-grade NAD+ is formulated strictly for in vitro and laboratory investigation.
PX1 Research supplies high-purity Nicotinamide Adenine Dinucleotide (NAD+) to academic, clinical, and private research institutions across Texas. Synthesized in GMP-compliant facilities and verified by independent ISO 17025 accredited laboratories, our research-grade NAD+ is formulated strictly for in vitro and laboratory investigation.
The expanding biomedical research infrastructure in Texas—spanning prominent university systems, biotechnology hubs in Austin and Houston, and specialized clinical research institutes—demands an uncompromised supply of high-purity cofactors and signaling molecules. When investigator teams require reference-grade materials to study metabolic regulation, sirtuin activation, or enzymatic kinetics, sourcing reliability and purity verification are paramount.
PX1 Research provides Texas-based laboratories with direct access to domestic, high-purity NAD+ research compounds. By eliminating the risks associated with international supply chains, such as customs delays, ambient thermal degradation, and inconsistent lot quality, PX1 Research ensures that investigators in Texas receive stable, fully characterized compounds ready for rigorous assay protocols.
Nicotinamide Adenine Dinucleotide (NAD+) is an essential dinucleotide coenzyme found in all living cells. Structurally composed of two nucleotides joined through their phosphate groups—one containing an adenine nucleobase and the other nicotinamide—NAD+ functions as a primary electron carrier in cellular redox reactions. It shuttles between its oxidized form, NAD+, and its reduced form, NADH, maintaining metabolic homeostasis.
Beyond its classic role as a redox coenzyme in glycolysis, the tricarboxylic acid (TCA) cycle, and mitochondrial oxidative phosphorylation, NAD+ acts as a required substrate for several classes of regulatory enzymes. These include class III histone deacetylases (sirtuins, SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38 and CD157). Preclinical studies suggest that the availability of NAD+ serves as a rate-limiting factor in governing these enzymatic pathways, directly influencing genomic stability, chromatin remodeling, and mitochondrial biogenesis in vitro.
In vitro data indicate that manipulating intracellular NAD+ pools alters mitochondrial respiration parameters and cellular stress response cascades. In primary cell cultures and isolated organelle assays, supplementation with high-purity NAD+ allows researchers to probe the precise threshold concentrations required to activate SIRT1 and SIRT3 downstream targets, such as PGC-1alpha and FOXO transcription factors.
Furthermore, animal model studies utilizing rodent tissues have demonstrated that decline in tissue NAD+ levels correlates with altered mitochondrial morphology and reduced oxidative capacity. Laboratory investigations examining metabolic flux often utilize research-grade NAD+ to establish baseline coenzyme stoichiometry, evaluating how enzymatic consumption by PARP enzymes under conditions of induced oxidative stress impacts overall ATP production. Researchers accessing our analytical library can review technical literature detailing these biochemical pathways.
To guarantee experimental reproducibility across longitudinal research projects, PX1 Research enforces strict quality control parameters for every batch of NAD+. Each synthesis lot undergoes rigorous analytical testing at an independent, ISO 17025 accredited laboratory. Purity is quantitative established using High-Performance Liquid Chromatography (HPLC), ensuring chemical purity consistently exceeds industry benchmarks.
In tandem with HPLC analysis, Mass Spectrometry (MS) is conducted to verify precise molecular mass and confirm the absence of synthesis side-products or degradation artifacts. Furthermore, every lot is subjected to bacterial endotoxin testing (LAL assay) to ensure compliance with strict limits (<0.01 EU/mg), making the compound ideal for sensitive cell culture experiments. A Certificate of Analysis (COA) detailing these metrics is generated per lot and made accessible to research personnel.
Cold-chain integrity and rapid transit times are critical factors when procuring biochemical reagents for laboratory research. International shipments are frequently subjected to regulatory impoundments, extended transit times, and uncontrolled temperature fluctuations that can compromise compound stability. PX1 Research mitigates these risks by operating centralized dispatch hubs located exclusively in California and Arizona.
For research facilities operating in Texas—including institutions in Dallas, Houston, San Antonio, and Austin—orders placed before cut-off times are dispatched the same day (Monday through Friday). Utilizing fast, direct domestic courier networks ensures transit times are minimized, delivering research compounds directly to facility receiving docks without customs friction or environmental degradation.
When designing protocols to investigate cellular bioenergetics, researchers frequently compare NAD+ with related nucleosides, metabolic precursors, and mitochondrial-targeted peptides. Understanding the distinct entry points and mechanisms of action within these molecular classes helps investigators select the appropriate primary research reagent.
While direct introduction of exogenous NAD+ allows for immediate substrate interaction in open cell systems or cell-free lysate assays, intermediate compounds such as Nicotinamide Mononucleotide (NMN) require enzymatic conversion via NMNAT enzymes to synthesize cellular NAD+. In contrast, peptide-based mitochondrial modulators operate through distinct receptor pathways: MOTS-c targets nuclear gene expression to regulate metabolic homeostasis, whereas the tetrapeptide SS-31 selectively binds to cardiolipin in the inner mitochondrial membrane to optimize electron transport without directly altering total dinucleotide coenzyme pools.
NAD+ is supplied as a lyophilized, highly purified powder to maximize stability during storage. For optimal long-term preservation, the un-reconstituted lyophilized compound should be stored in a freezer environment maintained at -20°C or lower, protected from light and atmospheric moisture.
When preparing working stock solutions for in vitro experiments, laboratory personnel should reconstitute the lyophilized powder using sterile, nuclease-free water or appropriate physiological buffer systems such as Phosphate-Buffered Saline (PBS). NAD+ exhibits high aqueous solubility. Due to the potential for hydrolysis in aqueous media over time, it is recommended to prepare single-use aliquots after reconstitution and freeze them rapidly at -80°C to avoid repeated freeze-thaw cycles.
PX1 Research supports university departments, core facilities, and contract research organizations (CROs) in Texas with streamlined procurement solutions. We accommodate standardized institutional purchase orders, enterprise vendor registration systems, and specialized delivery protocols required by academic and corporate receiving departments.
For high-throughput screening initiatives or ongoing multi-phase research projects requiring consistent material from a single synthesized lot, laboratories can utilize our specialized wholesale procurement portals. Enterprise accounts receive dedicated account coordination, guaranteed lot-reservation options, and scaled volume pricing to maximize research budget efficiency.
Where does PX1 Research ship NAD+ from when delivering to Texas?
All orders are dispatched directly from our domestic distribution centers in California and Arizona. This eliminates customs delays and ensures rapid, reliable transit to Texas research facilities.
Is the NAD+ supplied by PX1 Research suitable for human consumption?
No. All compounds offered by PX1 Research, including NAD+, are strictly for in vitro, cell culture, and laboratory research use only. They are not intended for human or veterinary administration, medical therapy, or clinical diagnostic procedures.
How is the purity and identity of each NAD+ lot verified?
Every synthesized lot undergoes independent testing at an ISO 17025 accredited laboratory using High-Performance Liquid Chromatography (HPLC) for purity analysis and Mass Spectrometry (MS) for structural identification. Endotoxin testing is also performed.
How should lyophilized NAD+ be stored upon arrival at our Texas lab?
Upon receipt, the lyophilized powder should be stored at -20°C or colder in a desiccated environment away from light. Once reconstituted into liquid solution, stock solutions should be aliquoted and stored at -80°C to maintain molecular stability.
What solvent is recommended for reconstituting research-grade NAD+?
NAD+ is readily soluble in sterile, nuclease-free laboratory-grade water or buffered solutions such as PBS. Reconstitution protocols should be performed under a laminar flow hood to maintain sterility.
Can Texas research institutions set up wholesale or bulk ordering accounts?
Yes, academic institutions, CROs, and private research labs in Texas can establish institutional accounts through our wholesale portal to access volume pricing, standing purchase orders, and single-lot reservation options.
Does PX1 Research provide a Certificate of Analysis (COA) with the shipment?
Yes. Each batch of NAD+ includes a lot-specific Certificate of Analysis detailing the HPLC purity percentage, MS molecular weight verification, and endotoxin assay results.
What are the primary molecular targets evaluated in preclinical NAD+ research?
Preclinical studies typically evaluate NAD+ as a required co-substrate for sirtuins (SIRT1-7), poly(ADP-ribose) polymerases (PARPs), and CD38/CD157 ectoenzymes involved in cellular signaling, DNA repair, and bioenergetics.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.